Page last updated: 2024-09-04

3,3',4'-trihydroxyflavone and pd 98059

3,3',4'-trihydroxyflavone has been researched along with pd 98059 in 1 studies

Compound Research Comparison

Studies
(3,3',4'-trihydroxyflavone)
Trials
(3,3',4'-trihydroxyflavone)
Recent Studies (post-2010)
(3,3',4'-trihydroxyflavone)
Studies
(pd 98059)
Trials
(pd 98059)
Recent Studies (post-2010) (pd 98059)
390224,93931,001

Protein Interaction Comparison

ProteinTaxonomy3,3',4'-trihydroxyflavone (IC50)pd 98059 (IC50)
RAF proto-oncogene serine/threonine-protein kinaseHomo sapiens (human)2.8
Luciferin 4-monooxygenasePhotinus pyralis (common eastern firefly)6.3
Amine oxidase [flavin-containing] BRattus norvegicus (Norway rat)2.8
Prostaglandin G/H synthase 1Homo sapiens (human)1
Mitogen-activated protein kinase 1Homo sapiens (human)2.8
Dual specificity mitogen-activated protein kinase kinase 2 Rattus norvegicus (Norway rat)4.2
Dual specificity mitogen-activated protein kinase kinase 1 Rattus norvegicus (Norway rat)4.2
Dual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)2.4

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kedikaetswe, A; Lim, NR; May, CN; Ng, DC; Thomas, CJ; Woodman, OL; Yeap, YY1

Other Studies

1 other study(ies) available for 3,3',4'-trihydroxyflavone and pd 98059

ArticleYear
Evidence that the MEK/ERK but not the PI3K/Akt pathway is required for protection from myocardial ischemia-reperfusion injury by 3',4'-dihydroxyflavonol.
    European journal of pharmacology, 2015, Jul-05, Volume: 758

    Topics: Animals; Cardiotonic Agents; Chromones; Drug Therapy, Combination; Female; Flavonoids; Flavonols; MAP Kinase Signaling System; Morpholines; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Primary Cell Culture; Prodrugs; Proto-Oncogene Proteins c-akt; Rats; Sheep; Signal Transduction

2015